Cargando…
Growth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering Applications
The highly sulfated glycosaminoglycan (GAG) heparin is widely used in the clinic as an anticoagulant, and researchers are now using it to enhance stem cell expansion/differentiation protocols, as well as to improve the delivery of growth factors for tissue engineering (TE) strategies. Growth differe...
Autores principales: | Ayerst, Bethanie I., Smith, Raymond A.A., Nurcombe, Victor, Day, Anthony J., Merry, Catherine L.R., Cool, Simon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397242/ https://www.ncbi.nlm.nih.gov/pubmed/27899064 http://dx.doi.org/10.1089/ten.tea.2016.0364 |
Ejemplares similares
-
The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications
por: Ayerst, Bethanie I., et al.
Publicado: (2017) -
Applications and Implications of Heparin and Protamine in Tissue Engineering and Regenerative Medicine
por: Nemeno, Judee Grace E., et al.
Publicado: (2014) -
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
por: Ling, Ling, et al.
Publicado: (2015) -
Engineered heparins as new anticoagulant drugs
por: Vaidyanathan, Deepika, et al.
Publicado: (2016) -
Heparines
por: de Graaf, Linda
Publicado: (2022)